ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ)
$3.79 0.26 (7.3654%)
Analysed ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) News Sources
Oramed: Q4 Earnings Snapshot
26-03-2026
yahoo.com
Lifeward Successfully Closes on Strategic Partnership with Oramed
25-03-2026
yahoo.com
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
13-03-2026
yahoo.com
ORMP: Enabling Participation in Both ORMP & LFWD Businesses Expected to Enhance Shareholder Value
26-02-2026
yahoo.com
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround
03-02-2026
fool.com
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.
03-02-2026
fool.com
3 Promising Penny Stocks With Market Caps Under $200M
14-01-2026
yahoo.com
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
13-01-2026
yahoo.com
Oramed and Lifeward Announce Strategic Transaction
13-01-2026
yahoo.com
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
07-01-2026
yahoo.com
What is the current price of ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ)?
The current price of ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) is $3.79.
ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) absolute price change since previous trading day?
The absolute price change of ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) since the previous trading day is $0.26.
ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) percentage price change since previous trading day?
The percentage price change of ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) since the previous trading day is 7.3654%.
What is the most recent average sentiment score for ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ)?
The most recent average sentiment score for ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ)?
The most recent sentiment for ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) is .
SEC-8K** Filing Available For ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.